Monday, March 11, 2013

Call for Public Comment: Antipsychotic Medication use Quality Measures


Centers for Medicare & Medicaid Services (CMS) has contracted with RTI International to develop antipsychotic medication use quality measures (AP QMs) in nursing homes. The purpose of the project is to develop quality measures that can be used to provide quality care to Medicare beneficiaries. The public comment period provides an opportunity for the widest array of interested parties to provide input on the measures under development and can provide critical suggestions not previously considered by the measure contractor or its technical expert panel (TEP).

Specific project objectives: The goal of this task is to develop nursing home quality measures for antipsychotic medication use with the following parameters: 1) The quality measures are MDS 3.0 based; 2) The quality measures focus on both long-stay and short-stay residents (i.e., one for long-stay and one for short-stay); 3) The quality measures take into account that antipsychotic medication use may be appropriate under certain conditions; and 4) measures should be submitted for NQF endorsement with as few exclusions at possible. The developed AP QMs should be appropriate for public reporting. To achieve these objectives, RTI solicits public comments on two AP QMs: Percent of Long-Stay Residents Who Receive an Antipsychotic Medication and Percent of Short-Stay Residents Who Newly Received an Antipsychotic Medication.

Instructions for Providing Comments:

  1. If you are providing comments on behalf of an organization, include the organization’s name and your contact information. 
  2. If you are commenting as an individual, submit identifying or contact information. 
  3. Please indicate which measures you are providing comments on. You may submit general comments on the entire set of measures or you may provide comments specific to individual measures. 
  4. At the end of the public comment period, all public comments will be posted on the CMS Web site

Email your comments to: APQMPublicComments@cms.hhs.gov. Comments are due by close of business March 15, 2013.

No comments:

Post a Comment